Brief: Sequana Medical Submits Premarket Approval Application To FDA For Alfapump

Sequana Medical NV

28/12/2023 06:03

Dec 28 (Reuters) - Sequana Medical NV  SEQUA.BR :
    * SEQUANA MEDICAL SUBMITS PREMARKET APPROVAL APPLICATION TO
US FDA
FOR ALFAPUMP® IN RECURRENT OR REFRACTORY ASCITES DUE TO LIVER
CIRRHOSIS
    * PMA FILING IS BASED ON SUCCESSFUL EXECUTION OF SEQUANA
MEDICAL'S
PIVOTAL POSEIDON STUDY

Source text for Eikon:  ID:nGNE3kKskC 
Further company coverage:  SEQUA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))